Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 24% ± 9% | |
astrocyte | 6 studies | 28% ± 10% | |
oligodendrocyte | 6 studies | 24% ± 6% | |
epithelial cell | 5 studies | 39% ± 13% | |
amacrine cell | 5 studies | 34% ± 9% | |
retina horizontal cell | 5 studies | 31% ± 11% | |
retinal rod cell | 5 studies | 20% ± 3% | |
Mueller cell | 5 studies | 24% ± 6% | |
GABAergic neuron | 5 studies | 38% ± 15% | |
interneuron | 5 studies | 33% ± 19% | |
neuron | 4 studies | 28% ± 8% | |
ciliated cell | 4 studies | 26% ± 6% | |
glutamatergic neuron | 4 studies | 50% ± 16% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 6% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 18% ± 2% | |
granule cell | 3 studies | 23% ± 6% | |
retinal ganglion cell | 3 studies | 24% ± 9% | |
retinal cone cell | 3 studies | 39% ± 10% | |
GABAergic amacrine cell | 3 studies | 23% ± 3% | |
glycinergic amacrine cell | 3 studies | 26% ± 2% | |
rod bipolar cell | 3 studies | 20% ± 4% | |
fibroblast | 3 studies | 21% ± 4% | |
hematopoietic precursor cell | 3 studies | 17% ± 1% | |
enteroendocrine cell | 3 studies | 27% ± 11% | |
basal cell | 3 studies | 36% ± 12% | |
goblet cell | 3 studies | 32% ± 13% | |
transit amplifying cell | 3 studies | 38% ± 25% | |
hepatocyte | 3 studies | 34% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 485.32 | 2642 / 2642 | 100% | 4.07 | 705 / 705 |
stomach | 100% | 248.89 | 359 / 359 | 100% | 3.42 | 286 / 286 |
breast | 100% | 325.05 | 459 / 459 | 100% | 4.70 | 1117 / 1118 |
prostate | 100% | 373.91 | 245 / 245 | 100% | 4.90 | 501 / 502 |
uterus | 100% | 324.21 | 170 / 170 | 100% | 3.99 | 458 / 459 |
bladder | 100% | 278.05 | 21 / 21 | 100% | 3.63 | 502 / 504 |
ovary | 100% | 334.93 | 180 / 180 | 100% | 3.60 | 428 / 430 |
esophagus | 100% | 259.23 | 1445 / 1445 | 99% | 3.62 | 182 / 183 |
intestine | 100% | 279.05 | 966 / 966 | 99% | 3.53 | 522 / 527 |
pancreas | 100% | 228.09 | 328 / 328 | 99% | 2.84 | 176 / 178 |
lung | 99% | 217.15 | 574 / 578 | 99% | 3.34 | 1149 / 1155 |
thymus | 100% | 316.69 | 653 / 653 | 98% | 2.78 | 594 / 605 |
kidney | 100% | 415.88 | 89 / 89 | 98% | 2.98 | 880 / 901 |
adrenal gland | 100% | 282.86 | 258 / 258 | 95% | 3.42 | 219 / 230 |
skin | 100% | 287.56 | 1806 / 1809 | 94% | 2.43 | 444 / 472 |
liver | 100% | 218.30 | 226 / 226 | 92% | 2.25 | 374 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.01 | 29 / 29 |
spleen | 100% | 296.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 3.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.26 | 1 / 1 |
adipose | 100% | 237.30 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 267.07 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 327.10 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 303.45 | 849 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 1.83 | 70 / 80 |
peripheral blood | 39% | 119.88 | 363 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006465 | Biological process | signal peptide processing |
GO_0008150 | Biological process | biological_process |
GO_0006627 | Biological process | protein processing involved in protein targeting to mitochondrion |
GO_0042720 | Cellular component | mitochondrial inner membrane peptidase complex |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
GO_0003674 | Molecular function | molecular_function |
Gene name | IMMP1L |
Protein name | Mitochondrial inner membrane protease subunit 1 (EC 3.4.21.-) (IMP1-like protein) Inner mitochondrial membrane peptidase subunit 1 Mitochondrial inner membrane protease subunit (EC 3.4.21.-) |
Synonyms | |
Description | FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . |
Accessions | A0A3B3IS22 ENST00000278200.5 ENST00000531331.1 H0YD09 ENST00000532287.6 Q96LU5 E9PIG6 E9PR99 ENST00000648582.1 ENST00000529749.5 E9PNR7 ENST00000530023.5 ENST00000526776.5 ENST00000533642.1 ENST00000534812.5 A0A0B4J221 |